Cargando…
Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?
Despite progress in understanding the pathophysiology of acute lung damage, currently approved treatment possibilities are limited to lung-protective ventilation, prone positioning, and supportive interventions. Various pharmacological approaches have also been tested, with neuromuscular blockers an...
Autores principales: | Mokra, Daniela, Mokry, Juraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919656/ https://www.ncbi.nlm.nih.gov/pubmed/33669167 http://dx.doi.org/10.3390/ijms22041929 |
Ejemplares similares
-
Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
por: Mokry, Juraj, et al.
Publicado: (2021) -
Corticosteroids in Acute Lung Injury: The Dilemma Continues
por: Mokra, Daniela, et al.
Publicado: (2019) -
Glucocorticoids in the treatment of neonatal meconium aspiration syndrome
por: Mokra, Daniela, et al.
Publicado: (2011) -
Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?
por: Mokra, Daniela, et al.
Publicado: (2022) -
Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis
por: Mokra, Daniela, et al.
Publicado: (2022)